Yifei Guo Selected Research

genkwanin

12/2020	Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer.
11/2017	Genkwanin nanosuspensions: a novel and potential antitumor drug in breast carcinoma therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifei Guo Research Topics

Disease

26	Neoplasms (Cancer) 06/2022 - 10/2013
9	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2016
2	Cough 06/2022 - 01/2022
2	Chronic Hepatitis B 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
2	Pain (Aches) 01/2017 - 01/2016
1	Cardiotoxicity 05/2022
1	COVID-19 01/2022
1	Hyperthyroidism 01/2022
1	Infections 01/2022
1	Non-alcoholic Fatty Liver Disease 09/2021
1	RNA Virus Infections 01/2021
1	Alcoholism (Alcohol Abuse) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 06/2019
1	Bone Resorption 06/2018
1	Postmenopausal Osteoporosis 06/2018
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Chronic Pain 01/2016
1	Vascular Diseases (Vascular Disease) 04/2014
1	Liver Neoplasms (Liver Cancer) 10/2013

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 05/2022 - 04/2014
5	homocamptothecinIBA 11/2018 - 10/2013
4	SolutionsIBA 06/2022 - 09/2016
4	Antineoplastic Agents (Antineoplastics)IBA 12/2020 - 11/2017
3	AcetogeninsIBA 06/2022 - 09/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 06/2019
3	polydopamineIBA 06/2019 - 11/2018
2	Antitussive Agents (Antitussives)FDA Link 06/2022 - 01/2022
2	Liposomes (Liposome)IBA 03/2022 - 03/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	icaritinIBA 10/2021 - 12/2020
2	CytokinesIBA 01/2021 - 01/2019
2	genkwaninIBA 12/2020 - 11/2017
2	FlavonoidsIBA 12/2020 - 12/2020
2	LigandsIBA 06/2019 - 11/2018
2	honokiolIBA 05/2019 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019 - 11/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018 - 01/2017
1	naringeninIBA 06/2022
1	Waste Products (Waste Product)IBA 06/2022
1	Amino Acids FDA Link 05/2022
1	EnzymesIBA 05/2022
1	Prostaglandins AIBA 05/2022
1	acceleratory factor from growth hormone (AcG)IBA 05/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Circular DNAIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	InterferonsIBA 01/2022
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2022
1	Excipients (Suspending Agents)IBA 10/2021
1	CarbonIBA 09/2021
1	bisphenol AIBA 09/2021
1	Therapeutic UsesIBA 05/2021
1	pterostilbeneIBA 05/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	TNF Receptor-Associated Factor 3IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Disulfiram (Antabuse)FDA Link 01/2020
1	SuspensionsIBA 01/2020
1	celastrolIBA 01/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2019
1	Dopamine (Intropin)FDA LinkGeneric 05/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 11/2018
1	Biocompatible Materials (Biomaterials)IBA 11/2018
1	naftopidilIBA 01/2017
1	protopanaxadiolIBA 09/2016
1	Tuberculin (PPD)IBA 09/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2016
1	Prostaglandins DIBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	hydroxycamptothecinumIBA 10/2013

Therapy/Procedure

14	Therapeutics 05/2022 - 09/2016
5	Drug Therapy (Chemotherapy) 05/2022 - 01/2016
2	Lasers (Laser) 05/2022 - 01/2017
2	Intravenous Injections 03/2022 - 01/2017
2	Oral Administration 12/2020 - 04/2014
1	Nanospheres 01/2018
1	Injections 01/2017
1	Pain Management 01/2016